Atlas Trials

TORL Biotherapeutics, LLC

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TORL Biotherapeutics, LLC

RecordFirmDate
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma (NCT07439653)TORL Biotherapeutics, LLC2026-03-31
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer (NCT07322094)TORL Biotherapeutics, LLC2025-12-10
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. (NCT06690775)TORL Biotherapeutics, LLC2024-11-20
A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer (NCT06005740)TORL Biotherapeutics, LLC2023-12-04
First in Human Study of TORL-3-600 in Participants With Advanced Cancer (NCT05948826)TORL Biotherapeutics, LLC2023-09-29
First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer (NCT05156866)TORL Biotherapeutics, LLC2022-02-02
First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer (NCT05159440)TORL Biotherapeutics, LLC2022-01-20
First in Human Study of TORL-1-23 in Participants With Advanced Cancer (NCT05103683)TORL Biotherapeutics, LLC2021-11-17

Track TORL Biotherapeutics, LLC automatically

Every clearance here is in the API, with alerts when new ones post.